受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:A2047 Batch: A204701
Alirocumab (anti-PCSK9) works by inhibiting the PCSK9 protein, which binds to the low-density lipoprotein receptor (LDLR) and causes receptor degradation, removing less LDL cholesterol from the circulation.
CAS No. | 1245916-14-6 |
---|---|
Formulation | PBS Buffer, PH 7.4 |
Isotype | human IGg1, κ |
Application | Alirocumab (anti-PCSK9) |
Source | CHO |
Storage (From the date of receipt) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles |
Shipping | Shipped under low temperature conditions |
Purity | 98% |
Protein concentration | 4.3mg/ml |
Endotoxin Level | <1 EU/mg |
人間や獣医の診断であるか治療的な使用のためにでない。